|
All Clinical trials
Citations 511-520 of 604 total displayed.
|
Past content
(since Jan 2000):
|
- ARTICLES
MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD
- C. R. Jack, Jr., M. Slomkowski, S. Gracon, T. M. Hoover, J. P. Felmlee, K. Stewart, Y. Xu, M. Shiung, P. C. O’Brien, R. Cha, D. Knopman, and R. C. Petersen
Neurology 2003; 60: 253-260.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Acute migraine treatment with droperidol: A randomized, double-blind, placebo-controlled trial
- S.D. Silberstein, W.B. Young, J.E. Mendizabal, J.F. Rothrock, and A.S. Alam
Neurology 2003; 60: 315-321.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
The use of topiramate in refractory status epilepticus
- A.R. Towne, L.K. Garnett, E.J. Waterhouse, L.D. Morton, and R.J. DeLorenzo
Neurology 2003; 60: 332-334.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Neutralizing antibodies during treatment of secondary progressive MS with interferon ß-1b
- C. Polman, L. Kappos, R. White, F. Dahlke, K. Beckmann, C. Pozzilli, A. Thompson, J. Petkau, and D. Miller
Neurology 2003; 60: 37-43.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Interferon ß-1a in primary progressive MS: An exploratory, randomized, controlled trial
- S.M. Leary, D.H. Miller, V.L. Stevenson, P.A. Brex, D.T. Chard, and A.J. Thompson
Neurology 2003; 60: 44-51.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD
- J.G. Nutt, K.J. Burchiel, C.L. Comella, J. Jankovic, A.E. Lang, E.R. Laws, Jr., A.M. Lozano, R.D. Penn, R.K. Simpson, Jr., M. Stacy, and G.F. Wooten
Neurology 2003; 60: 69-73.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Treatment of sporadic hemiplegic migraine with calcium-channel blocker verapamil
- Wengui Yu and Steven H. Horowitz
Neurology 2003; 60: 120-121.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Phase I study of thalidomide for the treatment of plexiform neurofibroma in neurofibromatosis 1
- A. Gupta, B.H. Cohen, P. Ruggieri, R.J. Packer, and P.C. Phillips
Neurology 2003; 60: 130-132.
[Abstract]
[Full text]
[PDF]
- CLINICAL/SCIENTIFIC NOTES
No additional benefit of HRT on response to rivastigmine in menopausal women with AD
- A.S. Rigaud, G. André, B. Vellas, J. Touchon, and J.J. Pere
Neurology 2003; 60: 148-a-149-a.
[Full text]
[PDF]
- CLINICAL/SCIENTIFIC NOTES
Dramatic response to chemotherapy in oligodendroglial gliomatosis cerebri
- Elie Louis, Florence Keime-Guibert, Jean-Yves Delattre, and Marc Sanson
Neurology 2003; 60: 151.
[Full text]
[PDF]
|
|
